Hubei Goto Biopharm Co.,Ltd.
SHZ: 300966.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Zubin Xi
- Employees
- 631
- Headquarters
- Yicheng, China
- IPO year
- 2021
- Market cap
- CN¥3.2B
- Website
- https://www.gotobiopharm.com/en
Loading 300966…
Loading profile data…Frequently asked questions about 300966
What does Hubei Goto Biopharm Co.,Ltd. (300966.SZ) do?
Hubei Goto Biopharm Co.,Ltd. engages in the production and sale of steroid hormone API's and intermediates in China. It offers starting materials, such as 9a-hydroxy-4-androstenedione(9a-OHAD), bisnoralcohol(BA), sitolactone, 1.4-androstadienedione(ADD), and 4-androstenedione(4-AD); intermediates, including estrogens, progesterone, nonsteroids,...
Where does 300966.SZ trade?
Hubei Goto Biopharm Co.,Ltd. (300966.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300966.SZ in?
Hubei Goto Biopharm Co.,Ltd. (300966.SZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Hubei Goto Biopharm Co.,Ltd.?
Zubin Xi is the chief executive officer of Hubei Goto Biopharm Co.,Ltd. (300966.SZ).
Where is Hubei Goto Biopharm Co.,Ltd. headquartered?
Hubei Goto Biopharm Co.,Ltd. is headquartered in China.
Does 300966.SZ pay a dividend?
Yes — Hubei Goto Biopharm Co.,Ltd. (300966.SZ) paid a trailing twelve-month dividend of CNY 0.02 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300966.SZ go public?
Hubei Goto Biopharm Co.,Ltd. (300966.SZ) completed its initial public offering in 2021.